These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11290430)

  • 1. Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma.
    Mughal TI; Goldman JM
    Eur J Cancer; 2001 Mar; 37(5):561-8. PubMed ID: 11290430
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic myelogenous leukemia.
    Kalidas M; Kantarjian H; Talpaz M
    JAMA; 2001 Aug 22-29; 286(8):895-8. PubMed ID: 11509034
    [No Abstract]   [Full Text] [Related]  

  • 3. Bcr-Abl inhibition as a modality of CML therapeutics.
    Buchdunger E; Matter A; Druker BJ
    Biochim Biophys Acta; 2001 Aug; 1551(1):M11-8. PubMed ID: 11553417
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML.
    McCann SR; Gately K; Conneally E; Lawler M
    Blood; 2003 Feb; 101(3):1200-1. PubMed ID: 12529295
    [No Abstract]   [Full Text] [Related]  

  • 5. STI571: a gene product-targeted therapy for leukemia.
    Mauro MJ; Druker BJ
    Curr Oncol Rep; 2001 May; 3(3):223-7. PubMed ID: 11296132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia.
    Mauro MJ; Druker BJ
    Curr Opin Oncol; 2001 Jan; 13(1):3-7. PubMed ID: 11148678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How I treat...chronic myeloid leukemia].
    Hafraoui K; Humblet-Baron S; Baron F; Beguin Y; Fillet G
    Rev Med Liege; 2003 Jan; 58(1):7-12. PubMed ID: 12647591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of advanced stage chronic myeloid leukemia].
    Takahashi N
    Rinsho Ketsueki; 2014 Oct; 55(10):1860-9. PubMed ID: 25297750
    [No Abstract]   [Full Text] [Related]  

  • 9. Restoration of donor chimerism by nilotinib in a chronic myeloid leukaemia patient post mutation-associated imatinib mesylate resistance and allogeneic stem cell transplant failure.
    O'Connor LM; Langabeer S; McCann SR; Conneally E
    Bone Marrow Transplant; 2008 Dec; 42(12):833-5. PubMed ID: 18711344
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent progress in diagnosis of and therapy for patients with leukemia].
    Ueda T
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):574-9. PubMed ID: 15052823
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myeloid leukemia. Introduction.
    Frame D
    Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S2-3. PubMed ID: 18056928
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic myelogenous leukaemia: recent progress in biology and therapeutic strategies].
    Turhan AG
    Bull Cancer; 2005 Jan; 92(1):75-82. PubMed ID: 15689327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position paper on imatinib mesylate in chronic myeloid leukaemia.
    O'Brien SG; Rule SA
    Br J Haematol; 2002 Oct; 119(1):268-72. PubMed ID: 12358935
    [No Abstract]   [Full Text] [Related]  

  • 14. Is b3a2 a better prognostic variant in childhood chronic myeloid leukemia?
    Malhotra KP; Sharma CB; Jain J; Grover RK
    J Postgrad Med; 2010; 56(3):221-2. PubMed ID: 20739774
    [No Abstract]   [Full Text] [Related]  

  • 15. hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia.
    Bazeos A; Marin D; Reid AG; Gerrard G; Milojkovic D; May PC; de Lavallade H; Garland P; Rezvani K; Apperley JF; Goldman JM; Foroni L; Khorashad JS
    Leukemia; 2010 Jun; 24(6):1243-5. PubMed ID: 20445576
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemia.
    Peggs K; Mackinnon S
    N Engl J Med; 2003 Mar; 348(11):1048-50. PubMed ID: 12637616
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic myeloid leukemia--advances in biology and new approaches to treatment.
    Goldman JM; Melo JV
    N Engl J Med; 2003 Oct; 349(15):1451-64. PubMed ID: 14534339
    [No Abstract]   [Full Text] [Related]  

  • 18. In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
    Sobrinho-Simões M; Wilczek V; Score J; Cross NC; Apperley JF; Melo JV
    Blood; 2010 Aug; 116(8):1329-35. PubMed ID: 20462961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.
    McCarron SL; Langabeer SE; Bolger K; Haslam K; Crampe M; Kelly J; Morrell R
    Med Oncol; 2015 Feb; 32(2):452. PubMed ID: 25579165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuing imatinib in chronic myeloid leukemia: don't try this at home.
    Mattison R; Larson RA
    Leuk Lymphoma; 2009 Jun; 50(6):868-70. PubMed ID: 19455466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.